RMD
ResMed · Health Care
4.5%
typical move (median |reaction| of last 8)
2026-10-19 pre
next expected · estimated from IR page
13
scored events
Last eight reactions
2025-01-30 → 2026-08-06
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-08-06 | post | -5.1% | 5.1% | +5.4% | +8.3% |
| 2026-07-07 | post | -6.3% | 6.3% | -4.9% | +5.6% |
| 2026-04-30 | post | -4.0% | 4.0% | -1.5% | -14.0% |
| 2026-01-29 | post | +0.3% | 0.3% | +5.3% | +0.6% |
| 2025-10-30 | post | -2.2% | 2.2% | +3.5% | +1.1% |
| 2025-07-31 | post | +2.6% | 2.6% | -0.8% | -5.1% |
| 2025-04-23 | post | +10.0% | 10.0% | -2.1% | -2.6% |
| 2025-01-30 | post | -8.2% | 8.2% | +0.3% | +1.8% |
Source filings
2026-08-06 · 8-K press release
For investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026 • Q4 revenue increased by
2026-07-07 · 8-K press release
Resmed Announces Agreement to Sell MatrixCare Business Sharpens Resmed’s focus on high-growth sleep and connected care markets SAN DIEGO, July 7, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD),
2026-04-30 · 8-K press release
For investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026 • Revenue increased by 11%
2026-01-29 · 8-K press release
For investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 • Revenue increased by 11%
2025-10-30 · 8-K press release
For investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 • Revenue increased by 9% t
2025-07-31 · 8-K press release
For investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025 • Year-over-year revenue g
2025-04-23 · 8-K press release
For investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025 • Year-over-year revenue gr
2025-01-30 · 8-K press release
For investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025 – Year-over-year revenue g